SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040040
Filing Date
2020-08-13
Accepted
2020-08-13 16:23:57
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20200630.htm 10-Q 1590763
2 EX-10.1 acer-ex101_264.htm EX-10.1 359003
3 EX-31.1 acer-ex311_6.htm EX-31.1 17832
4 EX-31.2 acer-ex312_8.htm EX-31.2 17514
5 EX-32.1 acer-ex321_7.htm EX-32.1 7887
6 EX-32.2 acer-ex322_9.htm EX-32.2 7686
7 GRAPHIC g25imub3hkuj000001.jpg GRAPHIC 13692
8 GRAPHIC g2jwkry21y0m000001.jpg GRAPHIC 1836
  Complete submission text file 0001564590-20-040040.txt   5336403

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT acer-20200630.xml EX-101.INS 750873
10 XBRL TAXONOMY EXTENSION SCHEMA acer-20200630.xsd EX-101.SCH 44178
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20200630_cal.xml EX-101.CAL 36737
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20200630_def.xml EX-101.DEF 144305
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20200630_lab.xml EX-101.LAB 376142
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20200630_pre.xml EX-101.PRE 270030
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 201099666
SIC: 2834 Pharmaceutical Preparations